DJ Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. $(GILD)$ shed 2.00% to $104.21 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.58% to 5,560.83 and the Dow Jones Industrial Average rising 0.75% to 40,527.62.
Gilead Sciences Inc. closed 13.13% short of its 52-week high of $119.96, which the company achieved on March 10th.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ rose 0.36% to $155.91, Pfizer Inc. $(PFE)$ rose 3.21% to $23.79, and Abbott Laboratories $(ABT)$ rose 0.75% to $130.50.
Trading volume (7.6 M) remained 2.3 million below its 50-day average volume of 9.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled April 29, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 29, 2025 16:36 ET (20:36 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。